Quantum Foods Holdings Ltd Overview
| Field | Detail | Source |
|---|---|---|
| Legal name | Quantum Foods Holdings Limited | HY2026 interim financial statements |
| Former names | None as a listed entity. Before October 2014 the business operated as the Quantum Foods division/subsidiary of Pioneer Food Group | Engineering News, 5 Sep 2014 |
| Registration number | 2013/208598/06 | All SENS filings |
| Incorporation | 2013, Republic of South Africa (Companies Act 71 of 2008) | 2025 Integrated Report |
| Listing | JSE Main Board, Prime Segment, since 2014 (unbundled from Pioneer Foods) | 2025 IR; Engineering News 2014 |
| Ticker | QFH (JSE); QFH.JO (Refinitiv-style) | SENS |
| ISIN | ZAE000193686 | SENS |
| CUSIP | Not applicable (no US listing) | — |
| Headquarters | 11 Main Road, Wellington 7655, Western Cape, South Africa | HY2026 interims |
| Fiscal year end | 30 September | AFS FY2025 |
| Auditor | Ernst & Young Inc. (designated auditor: PG (Pierre) du Plessis), appointed for FY2024 onward. Predecessor: PricewaterhouseCoopers Inc. (to FY2022/FY2023) | AFS FY2025; FY2022 summary results |
| Internal audit | Outsourced to Deloitte & Touche | AFS FY2025 ARC report |
| JSE sponsor | Valeo Capital (Pty) Ltd from 24 June 2026. Previously One Capital Sponsor Services | SENS 24 Jun 2026 |
| Transfer secretary | Computershare Investor Services (Pty) Ltd | HY2026 interims |
| Company secretary | Ziyanda Patience Wakashe (appointed 20 Sep 2022) | FY2022 summary results |
| Website | https://quantumfoods.co.za | Company website |
| Shares in issue | 204 097 828 (no treasury shares), as at 5 Oct 2026 | SENS 5 Oct 2026 |
| Share price (close) | 741 cents (13 Oct 2026) | ShareData / JSE |
| Market capitalisation | ~ZAR 1 512 M (741c x 204.1 M shares; analyst-computed) | Derived |
| Employees | 2 572 (FY2025), 2 425 (FY2024). FY2023 n/d in sources reviewed | 2025 IR |
| Operating countries | 4 (South Africa, Zambia, Uganda, Mozambique) | 2025 IR |
| B-BBEE level | Level 8 (FY2025 and FY2024) | 2025 IR |
Entity verification note
The identification details supplied (South Africa, JSE, QFH.JO, quantumfoods.co.za) match the entity profiled. There has been no name change and no change of listing. Quantum Foods Holdings Ltd remains listed on the JSE as at 14 October 2026.
An unrelated US company, Quantum Foods LLC (Bolingbrook, Illinois), went through Chapter 11 and was sold to Raging Bull Acquisition Co (Oaktree). It shares the name only.
Quantum Foods is a mid-sized, vertically integrated African protein producer spanning animal feed, poultry genetics and breeding, hatcheries, contract broiler farming, commercial layer farming and egg packing and distribution. It operates in South Africa, Zambia, Uganda and Mozambique.
Its revenue is ZAR 7.15 bn (FY2025). Animal feeds is the largest segment (46% of revenue), followed by broiler and layer farming (28%), eggs (18%) and other African operations (8%).
Quantum is one of South Africa's largest egg producers (Nulaid brand) and a long-term contract supplier of live broilers to Astral Foods' County Fair abattoir. It also holds the Lohmann layer-genetics licence for South Africa.
Since FY2024 the business has recovered from the 2023–2024 avian influenza crisis, delivering one of its best profit years since listing in FY2025, a net-cash balance sheet and a reinstated dividend. The equity story is dominated by a concentrated, contested shareholder register (four blockholders holding roughly 97%) and a protracted governance dispute. These factors suppress liquidity and the valuation multiple.
Company's own description (paraphrased from the 2025 Integrated Report)
Quantum describes itself as a diversified business built around animal feed, poultry and eggs. It operates in fragmented market segments where it is one of a few high-volume producers serving livestock farmers, processors and retailers in South Africa and selected other African markets.
Its stated purpose is to produce affordable, quality products responsibly. Its stated vision is to be the leading feed, poultry, livestock and protein business in Africa. It anchors its sustainability narrative in UN SDGs 2 (zero hunger), 8 (decent work) and 12 (responsible production).
Business model
| Product line | FY2025 | Share of group |
|---|---|---|
| Animal feeds | 3,391.7 | 47.5% |
| Broiler farming (day-old broiler chicks, live broilers) | 1,787.0 | 25.0% |
| Eggs (shell and liquid) | 1,603.8 | 22.4% |
| Layer farming (hatching eggs, day-old pullets, point-of-lay hens) | 364.1 | 5.1% |
| Total | 7,146.5 | 100% |
The group is a product-sales business. Revenue under IFRS 15 consists solely of the sale of goods: animal feed, livestock (day-old chicks, point-of-lay hens, live broilers, hatching eggs) and agricultural produce (eggs). There are no subscription, licensing or service revenue lines (AFS FY2025, accounting policy 14). Technical advisory services are bundled with feed sales and are not separately monetised.
Revenue by product type, FY2025 (ZAR M; AFS FY2025 revenue disaggregation, group-wide)
Value-chain position
Quantum is integrated from grandparent layer stock (Lohmann licence) and broiler parent stock (Ross 308) through to finished table eggs on retail shelves. It deliberately does not slaughter or process broilers. Since 2014 it has supplied live birds under long-term agreements, chiefly to Astral's County Fair operation in the Western Cape, and receives compensation for production risk rather than exposure to chicken-meat pricing (FY2022 summary results).
Its internal value flow runs as follows:
-
Feed mills supply internal farms (about 33% of FY2025 feed volume was consumed internally, versus 29% in FY2024).
-
Hatcheries supply internal and external farms.
-
Commercial layer farms supply the Nulaid egg business.
-
About 12% of FY2025 egg volume was bought from contracted external producers (15% in FY2024).
Customer types and end-markets
Commercial livestock farmers: (poultry, dairy, pig, ostrich, sheep): Nova Feeds customers.
Emerging and informal farmers: served through the bag-feed and depot model, mainly in the northern regions and Limpopo.
Commercial abattoirs: live broilers. Astral is the largest customer in the Western Cape broiler business.
Commercial egg producers: buyers of day-old pullets and point-of-lay hens, in South Africa and for export (Namibia, Eswatini, Angola).
Formal retail: branded and private-label shell eggs. Formal retail fell from 58.9% to 46.2% of egg volumes in FY2025 as the mix shifted.
Informal trade: spaza shops, wholesalers and hawkers via depots, under the Quantum Nest Eggs brand.
Industrial customers: liquid and pasteurised egg products.
Rest of Africa: feed, chicks and eggs sold through owned retail outlets (49 in Zambia), agents and direct farm sales.
Independent characterisation
Quantum is best understood as three different earnings engines with different cyclicality:
-
Feed and broiler farming: a cost-plus, volume-driven engine. Input-cost changes are passed through in selling prices, so earnings depend on volumes and efficiency. The company itself describes these units as more resilient to feed-cost swings.
-
Eggs and layer livestock: a commodity-spread engine. Egg prices are set by national supply and demand, not by production cost. Earnings therefore swing violently with the national layer-flock cycle, feed costs and avian influenza. Examples: an eggs adjusted operating loss of ZAR 42 M in FY2023 followed by a ZAR 140 M profit in FY2024, on lower revenue.
-
Other African countries: a small, higher-margin diversifier. It is exposed to currency translation (kwacha, shilling, metical), local grain harvests and political risk.
The strategic direction since FY2024 is to grow engine (1), rightsize engine (2) to about two-thirds of its pre-HPAI scale, and expand engine (3). The aim is to reduce earnings volatility.
Strategy
Stated strategy (2025 IR)
The strategy, adopted in FY2024, is titled "Re-focus, optimise and grow" and rests on five pillars:
-
Optimise business portfolio: clarity on each segment's strategic role and capital-allocation directives.
-
Growth: grow, scale or de-risk units to achieve sustainable profitability.
-
Efficient operations and customer focus, underpinned by four "drivers of success": quality, efficient operations, product performance and world-class customer service.
-
Human capital management: a people-centred business.
-
Organisational health: decentralised ownership, a reinvented culture and trust.
The 2026–2030 objectives (2025 IR) are to:
-
Pursue growth in less cyclical segments (feed and broiler farming).
-
Expand market share in South African day-old layer chicks.
-
Explore Lohmann genetics opportunities.
-
Position Zambia as a growth hub for the rest of Africa.
-
Expand process automation and AI in planning, flock-health monitoring, maintenance, logistics, recruitment and customer service.
Segment mandates (2025 IR)
| Segment | Mandate |
|---|---|
| Animal feeds | Grow volumes, share and earnings using the Malmesbury capacity |
| Eggs | Expect a "very challenging" FY2026, with cycle recovery forecast in 18–24 months. The business has been rightsized to about two-thirds of its pre-HPAI size, and sales will be redirected to more favourable channels |
| Broiler farming | Grow volumes through the Western Cape breeder-to-broiler conversion; become self-sufficient in breeder eggs |
| Bergvlei layer farming | Higher day-old chick volumes and exports; disciplined point-of-lay planning |
| Internal layer farming | Sustain efficiency; no growth unless HPAI vaccination becomes viable |
| Zambia | Grow through investment in Mega eggs and higher feed and chick sales over three years |
| Uganda | Maintain strong results |
| Mozambique | Follow the SA egg cycle; seek a partner or corporate transaction |
Strategic initiatives announced in the last 24 months
| Initiative | Status (latest) | Investment / target | Source |
|---|---|---|---|
| Malmesbury feed-mill expansion | Completed Feb 2026; expected to support H2 FY2026 earnings | ZAR 194 M approved Apr 2024 | 2025 IR; HY2026 |
| Gauteng broiler and layer-rearing farms converted to broiler breeders | Completed FY2025; driving HY2026 broiler earnings | ZAR 56 M retrofits and technology (FY2025) | AFS FY2025 |
| Western Cape breeder farm converted to broiler farm | Phase 1 near completion at Mar 2026; first placements May 2026 | +~6% live-bird capacity | HY2026 |
| Layer-breeder outsourcing / regional dispersal | Implemented; 4 of 6 breeder farms have Quantum-owned birds | Risk mitigation | AFS FY2025 |
| Leased Western Cape layer hatchery | Start-up phase in HY2026 | — | HY2026 |
| On-farm hatching pilot | Trial underway; business case due FY2026 | — | 2025 IR |
| Zambian Copperbelt egg and feed expansion | Land acquired; construction from H2 FY2026; multi-year | n/d (part of ZAR 313.9 M uncontracted capex commitments) | HY2026 |
| Uganda hatchery and breeder expansion; maize storage | 7th setter added Sep 2025; further breeder capacity planned | — | 2025 IR |
| Depot model / Quantum Nest Eggs expansion | Ongoing | — | 2025 IR |
| Mozambique corporate transaction / partner | Being pursued | — | 2025 IR |
| Digitalisation, automation and AI pilots | Pilots in FY2025 | — | AFS FY2025 |
| ESG: climate assessments, solar PV, water resilience, BiobiN® composting | Ongoing | — | 2025 IR |
Capital commitments (HY2026 note 6)
-
Approved and contracted: ZAR 63.4 M (30 Sep 2025: ZAR 87.3 M).
-
Approved but not yet contracted: ZAR 313.9 M (30 Sep 2025: ZAR 386.5 M).
Medium-term financial targets and guidance
The company publishes no quantitative medium-term financial targets and no numerical earnings guidance. The HY2026 outlook is qualitative:
-
A "significantly more challenging" H2 FY2026 is expected because of Middle East conflict effects on fuel and supply chains, and on consumers' disposable income.
-
Feed input costs are expected to stay relatively low in the short term.
-
Egg prices are expected to remain under pressure.
-
HPAI risk remains high.
-
The absence of load-shedding is positive.
-
Zambia is expected to be stable, Uganda challenged, and Mozambique challenging.
Products & Services
Pricing models are commercial and not disclosed. Feed and broiler prices are described as adjusted in line with input costs. Egg prices are market-determined. Broiler supply contracts compensate Quantum for production risk.
Animal feeds segment
| Brand / offering | Description and capabilities | Target customer | Year / version | Source |
|---|---|---|---|---|
| Nova Feeds (flagship feed brand) | More than 60 years of heritage. Customised formulations backed by technical advisers. Six feed mills on four SA sites. ISO 9000/14001/45000 and NOSA registration. On-site laboratories test all inputs and outputs | Commercial and emerging livestock farmers; internal farms (about 33% of volume) | Ongoing | 2025 IR |
| Broiler and layer poultry feed | Meal, pellet and crumble formats, bulk or bagged | Broiler and layer producers | Ongoing | 2025 IR |
| Dairy feed | Ruminant formulations; FY2025 customer forums improved dairy-herd performance | Dairy farmers | Ongoing | 2025 IR |
| Pig feed (fine-grind) | Ultra-finely milled feed from the new Malmesbury fine-grinding line | Pig producers | Commissioned Feb 2026 | 2025 IR; HY2026 |
| Ostrich and sheep feed | Specialist formulations | Ostrich and small-stock farmers (Western and Eastern Cape) | Ongoing | 2025 IR |
| Bag-feed and depot model | Bagged feed with chicks, medication and farm inputs sold through depots | Informal and emerging farmers (northern regions, Limpopo) | Expanding since FY2024 | AFS FY2025 |
| Feed consulting | Technical advice, formulation through the BESTMIX® system, on-farm performance service | Feed customers (bundled, not separately priced) | Ongoing | 2025 IR |
| New Malmesbury mill | ZAR 194 M expansion. Fine-grinding, precision mixers, pelleting, cooling. In-line protein and pellet-quality monitoring, a first for the group | Western Cape pig and broiler customers | Completed Feb 2026 | 2025 IR; HY2026 |
Farming segment — broiler farming
| Brand / offering | Description | Target customer | Year | Source |
|---|---|---|---|---|
| Bellevue Chix | Broiler breeding and hatchery brand: day-old broiler chicks of Ross 308 genetics (migration from Cobb 500 completed by FY2024) | Contract and open-market broiler growers; internal farms | Ross 308 conversion completed around 2023 | 2025 IR; HY2024 |
| Hatching eggs | From owned and contracted parent farms | Internal hatcheries | Ongoing | 2025 IR |
| Live broilers | Reared on 8 Western Cape broiler farms (6 owned, 2 long-term contracts) under long-term supply agreements | Commercial abattoirs, mainly Astral County Fair (about 600 000 broilers a week, about 35% of County Fair slaughter capacity, per Astral in Mar 2024) | Agreement dating from 2014; about five years remaining as of Mar 2024 | Astral release, 6 Mar 2024 |
| On-farm hatching (pilot) | Fertile eggs delivered to farms on day 18 to hatch in climate-controlled houses. Described as the first such trial in Africa; equipment sourced after a Belgian study tour (arrived Jun 2025) | Internal broiler operations | Business case due FY2026 | 2025 IR |
Farming segment — layer farming
| Brand / offering | Description | Target customer | Year | Source |
|---|---|---|---|---|
| Bergvlei Chicks | Layer genetics business: grandparent and parent breeding, two hatcheries, rearing farms. Sells day-old parent chicks, day-old commercial pullets, hatching eggs and point-of-lay hens | SA commercial egg farmers; exports to Namibia, Eswatini, Angola; indirect supply to Uganda via a Kenyan producer | Brand repositioned in FY2025 | AFS FY2025; 2025 IR |
| Lohmann genetics | Licence to import pedigree Lohmann grandparent layer stock. Parent stock distributed exclusively in South Africa and non-exclusively in selected African countries | Layer breeders and egg producers | Ongoing | 2025 IR |
| Point-of-lay hens | 17-week reared hens | Commercial egg farms | Volumes +110% in FY2025; -33.7% in HY2026 | 2025 IR; HY2026 |
| Day-old pullets | Female layer chicks | External and internal rearing | +28.1% in FY2025 | AFS FY2025 |
| Leased Western Cape layer hatchery | Second hatchery province, for HPAI risk dispersal | Internal / Bergvlei | Long-term lease secured FY2025; start-up costs in HY2026 | AFS FY2025; HY2026 |
Eggs segment
| Brand / offering | Description | Target customer | Source |
|---|---|---|---|
| Nulaid (flagship egg brand) | Branded shell eggs; FSSC 22000 or Food Safety certified grading and packing stations | Formal retail | 2025 IR |
| Quantum Nest Eggs | Value brand for the informal market, sold through depots | Spaza shops, wholesalers, informal traders | 2025 IR |
| Private-label eggs | Packed to retailer specification | National retailers | 2025 IR |
| Free-range eggs | From two dedicated farms | Premium retail | 2025 IR |
| Canola eggs | Specialty shell eggs | Premium retail | 2025 IR |
| Pasteurised shell eggs | Value-added shell eggs | Retail and food service | 2025 IR |
| Liquid egg (fresh and pasteurised) | Industrial ingredient; volumes -18.7% in FY2025 after a major customer was lost | Industrial food manufacturers | AFS FY2025 |
| Second-grade eggs and end-of-lay birds | By-products sold at depots | Informal market | 2025 IR |
Other African countries segment
| Country / brand | Products | Facilities | Source |
|---|---|---|---|
| Zambia: Mega (Mega Eggs) | Day-old pullets, day-old broiler chicks (external only), animal feed, table eggs; 49 company-owned small retail outlets | Parent breeding (layer and broiler), layer rearing farm, layer farm with packing station plus cull depot, hatchery, two feed mills (Lusaka, Chingola/Copperbelt). New Copperbelt greenfield farm acquired in HY2026 | 2025 IR; HY2026 |
| Uganda: Quantum Foods Uganda | Day-old pullets, day-old broiler chicks (Ross 308), Sasso-A1 dual-purpose chicks, feed and concentrates, table eggs; agents extend into Kenya, with exports to Tanzania | Layer rearing and laying farm with packing (Masindi), two owned and one rented breeder farms, hatchery (7th setter/hatcher added Sep 2025), feed mill | 2025 IR |
| Mozambique: Galovos | Table eggs (formal retail including SA retailers in Mozambique, and informal trade) | One layer farm and one egg packing facility (Maputo). Feed from third parties; point-of-lay birds from Quantum SA | 2025 IR |
Brand count. The 2025 IR states that the group has 8 commercial brands. Brands identifiable in the IR are Nova Feeds, Bellevue Chix, Bergvlei Chicks, Nulaid, Quantum Nest Eggs, Mega, Galovos and Quantum Foods Uganda. The exact eighth-brand designation could not be confirmed from the text reviewed.
Operating volumes (2025 IR; HY2026 interims)
| Volume metric | FY2024 | FY2025 | HY2026 vs HY2025 |
|---|---|---|---|
| Feed supplied (tonnes) | 671,209 | 731,328 | -2.6% (external -3.8%) |
| Day-old chicks produced (million) | 82 | 86 | Broiler DOC +9.1% |
| Eggs and egg products sold (million) | 531 | 828 | Egg supply +4.4% |
| Live broilers | — | -0.3% YoY | +3.3% |
Financial Narrative
All figures are audited group figures in ZAR M unless stated. Sources: FY2022 summary results (FY2021–FY2022), HY2024 interims (FY2023 audited column), HY2025 interims (FY2024 audited column), HY2026 interims and AFS FY2025 (FY2025).
Income statement — chartable
EBITDA: n/d. Reference point: as at 31 March 2024 the company reported EBITDA-to-senior-interest covenant cover of 18.14x against a 4.50x minimum (HY2024 interims, note 2).
Margins — chartable (analyst-computed)
Management also reports gross margin excluding realised fair-value adjustments on biological assets and agricultural produce:
-
FY2021: 21.3%
-
FY2022: 18.5%
-
FY2024: 22.1%
-
FY2025: 23.1% (ZAR 1.65 bn)
-
HY2026: 25.2%
-
FY2023: n/d in sources reviewed
Revenue CAGR FY2021–FY2025: 7.3% a year (analyst-computed). Breakdown: South Africa 6.8% a year; Other African countries 14.2% a year.
Balance sheet — chartable
Notes:
-
Negative net debt indicates a net cash position.
-
Goodwill: ZAR 5.4 M (Olifantskop) was fully impaired in FY2022. No goodwill has been recognised since.
-
HY2026 (31 Mar 2026): total assets ZAR 3 675.1 M; cash ZAR 476.4 M; term loan ZAR 69.6 M; leases ZAR 47.1 M. Net cash ZAR 359.7 M including leases. Equity ZAR 2 548.3 M.
Cash flow — chartable
Notes:
Buybacks: none for cancellation in FY2021–FY2025 (AFS FY2025 directors' report). Subsidiaries buy treasury shares only to settle share appreciation rights: ZAR 2.3 M (FY2023), ZAR 8.6 M (FY2024, offset by issue) and ZAR 18.8 M in HY2025 (offset by issue).
HY2026: OCF ZAR 408.7 M (including a working-capital release of ZAR 125.0 M); capex ZAR 152.1 M; dividends paid ZAR 68.8 M.
Ratios — chartable (analyst-computed)
Methodology notes:
ROIC: operating profit x (1 – statutory tax rate of 28% to FY2022 and 27% from FY2023) / (equity + debt including leases – cash).
Cash conversion cycle: receivable days + inventory days – payable days, using year-end balances. It excludes biological assets. Receivables and payables include "other" balances, so the figure is indicative only and is not a company disclosure.
Net debt/EBITDA: not meaningful, because the group was in net cash from FY2023, and EBITDA is n/d.
Trend commentary
FY2021 to FY2022: margin compression.
Revenue rose 11.5% on price pass-through. However, maize and soy costs rose about 15% each, egg prices could not keep pace in a weak consumer market, load-shedding intensified, HPAI struck Lemoenkloof and the Kaalfontein strike disrupted production. Adjusted operating profit fell 74% to ZAR 37 M. A working-capital build of ZAR 259 M in FY2021 pushed free cash flow negative in both years, and the group ended FY2022 with a net overdraft of ZAR 11 M (FY2022 summary results).
FY2023: the trough.
Revenue rose 15.5% to ZAR 6.95 bn, almost entirely from feed price inflation. The H7 HPAI outbreak in the northern provinces destroyed ZAR 155.3 M of birds, equivalent to 56.8c of EPS. Diesel and generator costs rose by about ZAR 87 M (Business Report, Dec 2023). The group posted its first operating loss since listing (ZAR -36 M) and a headline loss of 17.4c. Cash generation nevertheless improved, as working capital unwound and OCF reached ZAR 276 M.
FY2024: revenue down, profit up.
Revenue fell 8.9% as feed volumes dropped and egg volumes collapsed. Scarcity, however, drove egg prices up sharply, and the eggs segment earned ZAR 140 M. Farming still lost ZAR 11 M, after a further ZAR 37 M in HPAI write-offs. HEPS recovered to 80.4c. The RMB term loan of ZAR 100 M lifted liquidity; cash ended at ZAR 246 M.
FY2025: volume-led recovery.
Revenue rose 12.9% to ZAR 7.15 bn, with egg volumes up 79.5% and feed volumes up 8.7%. Farming swung to a ZAR 127 M profit. The CFO described it as one of the best profit performances since the unbundling. Head-office costs fell from ZAR 37 M to ZAR 23 M as spending on corporate and legal matters declined. Capex nearly doubled to ZAR 261 M (Malmesbury mill, breeder-farm conversions), which compressed free cash flow to about ZAR 40 M. A dividend of 34c was reinstated.
HY2026: margin-led inflection.
Revenue fell 4.8% on lower feed prices and egg prices (-8.8%). Gross margin excluding fair-value adjustments rose to 25.2%, and HEPS rose 16% to 86.5c. Notable features of the half:
-
The other African countries segment generated 22% of segment profit.
-
Cash reached ZAR 476 M.
-
Head-office costs rose because the share appreciation rights scheme moved to cash settlement, which made reported costs sensitive to the share price.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Income Statement and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (ZAR Mn) | 5,401.1 | 6,020.6 | 6,952.6 | 6,332.1 | 7,146.5 |
Cost of sales (ZAR Mn) | 4,339.0 | 4,910.9 | 5,769.7 | 5,107.3 | 5,691.0 |
Gross profit as reported (ZAR Mn) | 1,062.1 | 1,109.6 | 1,182.9 | 1,224.8 | 1,455.5 |
Other gains/(losses) net (ZAR Mn) | 72.3 | -5.9 | -66.4 | 185.2 | 192.0 |
Operating profit (ZAR Mn) | 147.6 | 32.5 | -35.9 | 230.9 | 368.6 |
Adjusted operating profit before capital items (ZAR Mn) | 144.3 | 36.8 | -34.7 | 232.2 | 360.7 |
Investment income (ZAR Mn) | 4.7 | 4.2 | 5.5 | 8.0 | 22.0 |
Finance costs (ZAR Mn) | 11.8 | 16.3 | 23.6 | 19.8 | 16.6 |
Profit before tax (ZAR Mn) | 142.3 | 20.3 | -53.0 | 219.9 | 374.9 |
Income tax expense/(credit) (ZAR Mn) | 36.5 | -3.6 | -17.4 | 59.5 | 96.2 |
Net profit attributable to owners (ZAR Mn) | 105.8 | 23.8 | -35.6 | 160.4 | 278.6 |
Headline earnings (ZAR Mn) | 102.3 | 28.1 | -34.8 | 161.3 | 271.7 |
Basic EPS (ZAR cents) | 53.9 | 12.0 | -17.8 | 80.0 | 137.8 |
Diluted EPS (ZAR cents) | 53.0 | 11.9 | -17.8 | 78.8 | 137.1 |
HEPS (ZAR cents) | 52.2 | 14.1 | -17.4 | 80.4 | 134.4 |
Dividend per share declared for year (ZAR cents) | 0 | 8.0 | 0 | 0 | 34.0 |
Weighted average shares (million) | 196.1 | 198.8 | 199.6 | 200.6 | 202.2 |
Margin (%)
| Margin (%) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross margin as reported | 19.7 | 18.4 | 17.0 | 19.3 | 20.4 |
Operating margin | 2.7 | 0.5 | -0.5 | 3.6 | 5.2 |
Adjusted operating margin | 2.7 | 0.6 | -0.5 | 3.7 | 5.0 |
Pre-tax margin | 2.6 | 0.3 | -0.8 | 3.5 | 5.2 |
Net margin | 2.0 | 0.4 | -0.5 | 2.5 | 3.9 |
Balance Sheet
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets (ZAR Mn) | 2,784.5 | 3,130.8 | 2,933.6 | 3,215.4 | 3,475.9 |
Property plant and equipment (ZAR Mn) | 1,243.1 | 1,322.7 | 1,353.3 | 1,368.2 | 1,543.4 |
Biological assets (ZAR Mn) | 403.3 | 433.9 | 338.4 | 460.1 | 460.0 |
Inventories (ZAR Mn) | 383.5 | 463.8 | 415.6 | 361.9 | 367.9 |
Current trade and other receivables (ZAR Mn) | 562.9 | 750.6 | 687.8 | 718.6 | 749.1 |
Cash and equivalents (ZAR Mn) | 73.3 | 63.8 | 71.4 | 245.8 | 275.9 |
Intangible assets incl goodwill (ZAR Mn) | 7.1 | 11.6 | 12.3 | 9.0 | 6.5 |
Bank overdraft and term loan short-term (ZAR Mn) | 0 | 74.9 | 0 | 20.0 | 20.0 |
Term loan long-term (ZAR Mn) | 0 | 0 | 0 | 79.4 | 59.6 |
Lease liabilities total (ZAR Mn) | 109.0 | 81.6 | 43.2 | 43.1 | 54.9 |
Total debt incl leases (ZAR Mn) | 109.0 | 156.5 | 43.2 | 142.5 | 134.4 |
Net debt incl leases (ZAR Mn) | 35.7 | 92.7 | -28.2 | -103.3 | -141.4 |
Total equity (ZAR Mn) | 1,999.8 | 2,100.8 | 2,015.9 | 2,094.7 | 2,395.1 |
Working capital (ZAR Mn) | 999.3 | 1,006.0 | 861.3 | 1,048.9 | 1,198.3 |
Trade and other payables (ZAR Mn) | 396.7 | 603.6 | 627.9 | 696.5 | 605.3 |
Cash Flow
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Cash profit from operations (ZAR Mn) | 295.3 | 170.6 | 232.2 | 384.9 | 529.9 |
Working capital change (ZAR Mn) | -259.3 | -87.1 | 52.5 | -110.1 | -173.9 |
Operating cash flow (ZAR Mn) | 24.3 | 77.8 | 276.4 | 264.3 | 301.8 |
Capex PPE plus intangibles (ZAR Mn) | 108.6 | 125.2 | 142.5 | 153.4 | 261.9 |
Free cash flow OCF minus capex (ZAR Mn) | -84.3 | -47.4 | 133.9 | 110.9 | 39.9 |
Dividends paid (ZAR Mn) | 19.4 | 16.0 | 0.1 | 0.0 | 0.0 |
Lease principal repaid (ZAR Mn) | 20.9 | 24.0 | 24.9 | 19.9 | 15.9 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROE on year-end equity (%) | 5.3 | 1.1 | -1.8 | 7.7 | 11.6 |
ROA on year-end assets (%) | 3.8 | 0.8 | -1.2 | 5.0 | 8.0 |
ROIC indicative after-tax (%) | 5.2 | 1.1 | -1.3 | 8.5 | 11.9 |
Current ratio (x) | 3.35 | 2.42 | 2.32 | 2.42 | 2.83 |
Debt to equity incl leases (%) | 5.5 | 7.4 | 2.1 | 6.8 | 5.6 |
Interest cover operating profit / finance costs (x) | 12.5 | 2.0 | -1.5 | 11.7 | 22.3 |
Asset turnover revenue / year-end assets (x) | 1.94 | 1.92 | 2.37 | 1.97 | 2.06 |
Cash conversion cycle indicative (days) | 36.9 | 35.1 | 22.7 | 17.5 | 22.9 |
Region revenue (ZAR Mn)
| Region revenue (ZAR Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
South Africa | 5,080.9 | 5,626.1 | 6,509.8 | 5,864.2 | 6,601.5 |
Other African countries (Zambia, Uganda, Mozambique) | 320.2 | 394.4 | 442.8 | 467.9 | 545.0 |
Region revenue growth (%)
| Region revenue growth (%) | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
South Africa | 10.7 | 15.7 | -9.9 | 12.6 |
Other African countries | 23.2 | 12.3 | 5.7 | 16.5 |
Region share of group revenue (%)
| Region share of group revenue (%) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
South Africa | 94.1 | 93.4 | 93.6 | 92.6 | 92.4 |
Other African countries | 5.9 | 6.6 | 6.4 | 7.4 | 7.6 |
Other African countries revenue by product (ZAR Mn)
| Other African countries revenue by product (ZAR Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Eggs | 206.6 | 252.6 | 304.8 | 315.1 | 340.6 |
Broiler farming (chicks) | 33.5 | 60.5 | 48.0 | 74.3 | 75.5 |
Layer farming (pullets) | 36.6 | 29.1 | 34.2 | 45.8 | 50.6 |
Animal feeds | 43.6 | 52.3 | 55.8 | 32.6 | 78.3 |
Group revenue by product (ZAR Mn)
| Group revenue by product (ZAR Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Animal feeds | 2,484.1 | 2,740.5 | 3,414.6 | 3,171.4 | 3,391.7 |
Broiler farming | 1,225.5 | 1,436.4 | 1,689.5 | 1,773.1 | 1,787.0 |
Eggs | 1,435.4 | 1,602.7 | 1,627.1 | 1,174.1 | 1,603.8 |
Layer farming | 256.2 | 241.0 | 221.4 | 213.5 | 364.1 |
Share Price History
| Date | Price (c) | Context | Source |
|---|---|---|---|
13 Nov 2023 | 435 | Post-HPAI loss trading statement | Business Report |
1–7 Mar 2024 | +104.4% | Astral stake sold to CBH at 725c | Business Report |
2 Dec 2024 | 850 | FY2024 results | Business Report |
12 Sep 2025 | 712 | — | ShareData |
17 Feb 2026 | 999 | SAR modification valuation price | HY2026 note 2 |
11 Mar 2026 | 1,190 | Pre-AGM | ShareData |
30 Apr 2026 | 1,098 | Market cap ZAR 2.24 bn | ShareData |
14 Jul 2026 | 915 | Market cap ZAR 1.87 bn | ShareData |
13 Oct 2026 | 741 | Latest close | ShareData |
Valuation Snapshot
| Metric | Value | Basis |
|---|---|---|
Market capitalisation | ZAR 1 512 M | 204.1 M shares |
Enterprise value | ZAR 1 152 M | Less net cash of ZAR 359.7 M including leases |
TTM revenue | ZAR 6 972 M | FY2025 – HY2025 + HY2026 |
TTM operating profit | ZAR 405 M | Same method |
TTM EPS | 153.7c | 137.8 – 74.5 + 90.4 |
TTM HEPS | 146.1c | 134.4 – 74.8 + 86.5 |
P/E (on EPS) | 4.8x | — |
P/E (on HEPS) | 5.1x | — |
EV/Sales | 0.17x | — |
EV/operating profit (EBIT) | 2.8x | — |
P/B | 0.59x | NAV of 1 249c per share (equity ZAR 2 548 M) |
TTM dividend yield | 7.6% | 34c + 22c = 56c |
Dividend per share declared (ZAR cents)
| Dividend per share declared (ZAR cents) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Interim | 0 | 8.0 | 0 | 0 | 0 |
Final | 0 | 0 | 0 | 0 | 34.0 |
Total | 0 | 8.0 | 0 | 0 | 34.0 |
Capital Instruments
| Instrument | Amount (ZAR Mn) | Terms | Maturity |
|---|---|---|---|
MYR Bn term loan: current portion | 20.0 | 3-month JIBAR + 2.3% (moving to ZARONIA from Dec 2026); secured by mortgage and notarial bonds of up to ZAR 300 M; semi-annual instalments | Within 12 months |
MYR Bn term loan: non-current | 49.6 | As above | To 30 Sep 2028 |
IFRS 16 lease liabilities | 47.1 | Farms, equipment, properties, vehicles; typically 2–5 years | 13.2 current; 33.9 non-current |
Covenant Details
| Covenant | Limit | Actual (31 Mar 2024) |
|---|---|---|
Gross debt to equity | ≤30% | 2.73% |
Equity | ≥ZAR 1.8 bn | ZAR 2.02 bn |
Current ratio |
| 2.65x |
EBITDA / senior interest | ≥4.5x | 18.14x |
Analyst Conclusions
Management guidance (HY2026 outlook, 22 May 2026)
Guidance is qualitative only:
-
H2 FY2026 is expected to be significantly more challenging, because Middle East-driven fuel and logistics costs affect both the cost base and consumer spending.
-
Feed raw materials are expected to stay relatively low in the short term.
-
South African egg prices are expected to remain under pressure because of an elevated national flock.
-
HPAI risk remains high, and a vaccination protocol is not yet commercially feasible.
-
No load-shedding is expected, which is positive.
-
Zambia is expected to be stable, Uganda's H1 strength hard to repeat, and Mozambique challenging.
-
New Malmesbury capacity and broiler farm placements will contribute in H2.
Consensus growth expectations
n/d (no published consensus).
Bull case
-
Structural de-risking is working. Feed, broiler and Africa together generated ZAR 208.7 M of HY2026 adjusted operating profit, against ZAR 41.5 M from eggs. A lower-volatility earnings base deserves a higher multiple than about 5x earnings and 0.6x book.
-
Capacity is arriving into demand. The Malmesbury mill was at full capacity before expansion; day-old broiler chick volumes rose 9.1% after the northern breeder conversions; and the Western Cape broiler conversion adds about 6% capacity. Volume growth could offset deflation in feed and egg prices.
-
Cash and a corporate catalyst. Net cash of about ZAR 360 M (about 24% of market cap) and a 7.6% trailing yield. The two ROFR blocs make an eventual control transaction plausible, which could crystallise value toward NAV of 1 249c, about 69% above 741c.
Bear case
-
Eggs are entering a down-cycle. Management's own 18–24-month egg recovery forecast, the record national flock and the -8.8% HY2026 price move imply further egg-margin erosion. Any rise in feed costs would amplify losses, as in FY2022 and FY2023.
-
HPAI remains an unhedged tail risk. A single severe outbreak cost ZAR 155 M in FY2023, more than half of FY2025 net profit. A commercially workable vaccination protocol is still absent.
-
Governance is deteriorating, not stabilising. NED pay was rejected again in October 2026 (79.90% against the chair's back-pay). The blockholders include direct competitors. Free float is about 3% and institutional holding zero. The shares can stay structurally discounted with no market mechanism to close the gap.
Key catalysts and monitorables (next 12 months)
| Expected timing | Catalyst |
|---|---|
| ~Nov 2026 | FY2026 trading statement, then audited results. Watch H2 egg margins, feed volumes from Malmesbury, and the final dividend decision |
| Ongoing | Board response to the failed NED remuneration resolutions (5 Oct 2026). Possible chair change, requisitioned meetings or a revised proposal |
| Ongoing | Any exercise of the ROFRs or acquisition by Capitalworks, Aristotle, CBH or Braemar. A move above 35% would trigger a mandatory offer under SA takeover rules |
| Ongoing | Seasonal HPAI incidence (southern-hemisphere winter, May–Sep) and progress on a vaccination protocol |
| Ongoing | Competition Commission Poultry Market Inquiry findings (about early-to-mid 2027) |
| ~Mar 2027 | FY2026 AGM. NED remuneration and director elections become a referendum on the chair |
| Ongoing | Mozambique transaction; Zambian Copperbelt build progress; Golden appeal outcome |
| Ongoing | Astral broiler supply agreement visibility ahead of its roughly 2029 expiry |
Analyst verdict
Operationally, Quantum Foods enters FY2027 in better shape than at any point since its 2014 unbundling. It has recovered from back-to-back avian influenza disasters to deliver FY2025 HEPS of 134.4c and a further 16% rise in HY2026. The balance sheet is net cash. It has a newly commissioned feed mill, rebalanced breeder capacity and a fast-growing African business that now contributes more than a fifth of segment profit.
Management has executed credibly on a clear strategy: shift capital toward the less cyclical feed and broiler businesses, rightsize the volatile egg business, and diversify geographically. On the numbers alone, a stock trading at about 5x trailing earnings, 0.6x book and a 7.6% yield looks mispriced.
The discount, however, is not an accident. Quantum is in effect a listed private company. Four blockholders control about 97% of the shares; two of them own competing poultry businesses; and they are arranged in opposing ROFR blocs that could each approach or exceed control. The board has survived one removal vote by a 1.6-percentage-point margin. A court has ordered a director reinstated. And shareholders have now twice refused to pay the non-executives, most recently voting almost four-to-one against the chairman's remuneration.
That conflict is unlikely to resolve organically. It is more likely to end in a control transaction, a board reconstitution, or prolonged attrition that distracts management during an egg down-cycle.
Our synthesis is that Quantum is a fundamentally improving but un-investable-at-scale special situation. Value realisation depends less on operations than on how the shareholder contest is resolved. For strategic or event-driven investors, the asymmetry is attractive: downside is cushioned by net cash and tangible assets, and upside comes from a potential offer toward NAV. For conventional institutional mandates, illiquidity, concentration, HPAI tail risk and a governance standoff that worsened in October 2026 remain disqualifying until a resolution is visible.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Director | Role | Independence | Appointed / tenure | Background (as disclosed in sources reviewed) |
|---|---|---|---|---|
Wouter André (André) Hanekom | Chairman, non-executive | Not classified independent | Board since 2014; chair since 2015 | Former CEO of Pioneer Foods. Survived removal votes in Sep 2024 (49.21% for removal). Re-elected Mar 2026 |
Geoffrey George Fortuin | Lead independent director; Audit and Risk Committee (ARC) chair | Independent | Board since at least 2022 (exact date n/d) | Survived removal vote in Sep 2024 |
Larry Wilson Riddle | Independent NED; ARC member | Independent | Board since at least 2022 (exact date n/d) | Braemar sought his removal in 2024 (meeting never convened) |
Gary Vaughan-Smith | Non-executive director | Not classified independent | Board since at least 2022 (exact date n/d) | Widely associated with SilverStreet Capital, adviser to Silverlands II / Aristotle Africa (the largest shareholder). Confirm against the 2025 IR board biography |
Pieter Francois Theron (Piet) Burger | Independent NED; ARC and SETC member | Independent | 29 Jul 2024 | BEng (Chemical) and MBA (Stellenbosch); former executive at Tiger Brands and Pioneer Foods; more than 30 years in manufacturing |
RW Dobbie | Independent NED | Independent | Elected 26 Mar 2026 | Biography n/d in sources reviewed |
JG Hudson | Independent NED | Independent | Elected 26 Mar 2026 | Biography n/d in sources reviewed |
SBC Johnson | Independent NED | Independent | Elected 26 Mar 2026 | Biography n/d in sources reviewed |
S Reid | Independent NED | Independent | Elected 26 Mar 2026 | Biography n/d in sources reviewed |
Adel Deidré van der Merwe | Chief Executive Officer | Executive | CEO since 1 Apr 2024 | Prior Quantum roles n/d in sources reviewed |
André Hugo Muller | Chief Financial Officer | Executive | CFO since at least FY2020 (exact date n/d) | CA(SA) |
Board & Management Changes
| Date | Change |
|---|---|
1 Apr 2024 | HA (Hennie) Lourens retires as CEO (leaves board 31 May 2024); AD van der Merwe appointed CEO |
31 May 2024 | TJA Golden leaves the board (disputed as a "summary removal"; WC High Court ordered reinstatement in Nov 2024; leave to appeal sought) |
29 Jul 2024 | PFT Burger appointed independent NED |
11 Sep 2024 | Shareholder resolutions to remove Hanekom, Fortuin and Burger fail |
26 Mar 2026 | RW Dobbie, JG Hudson, SBC Johnson and S Reid elected independent NEDs |
7 and 9 Apr 2026 | "Director's integrity information" announcements published (content n/d in sources reviewed) |
Major Shareholders
| Holder | Ultimate party | Latest disclosed / estimated stake | Basis and date |
|---|---|---|---|
Aristotle Africa S.à r.l. | Silverlands II SCSp (advised by SilverStreet Capital LLP, London) | ~34.2–34.5% | 34.2% per company statement Mar 2024 (Just Food). Profile's Handbook lists a 34.46% holder (Jun/Oct 2025); attribution inferred |
Braemar Trading Ltd | Associated with the Rudland family (Zimbabwe) | ~30.5–31% | 30.8% in Mar 2024. Implied about 30.5% from the CBH and Braemar combined 47.54% (Jul 2025) |
Country Bird Holdings (Pty) Ltd (CBH) | Private SA poultry integrator | ~17.0–18% | 15.8% in Mar 2024, about 18% by Jul 2024 (BusinessDay). Profile's Handbook lists a 17.04% holder |
Capitalworks Private Equity SP GP II (Special Purpose Acquisition Partnership IV) with Crown Chickens (Pty) Ltd (Sovereign Food Investments subsidiary) | Capitalworks Investment Partners | 15.53% of net shares | SENS 12 Jun 2025 |
Directors and other public | — | ~2–3% (implied residual) | Analyst-computed residual |
Competitive Landscape
Key Competitors
| Competitor | Segments overlapping | Status | Latest revenue | Positioning vs Quantum |
|---|---|---|---|---|
Astral Foods (JSE: ARL) | Feed (Meadow Feeds), broiler breeding and day-old chicks, broilers | Listed | ZAR 22.6 bn FY2025 (Sep YE); PBIT ZAR 1.25 bn | About 3x Quantum's scale; also Quantum's largest broiler customer. Led the HPAI vaccination pilot |
Rainbow Chicken (JSE: RBO; unbundled from RCL Jul 2024) | Broilers, animal feed (Epol, Driehoek) | Listed | ZAR 17.1 bn FY2026 (Jun YE); EBITDA ZAR 2.13 bn | About 390 000 t of chicken and about 1 M t of feed a year (BusinessDay, Aug 2026) |
Country Bird Holdings (CBH) | Feed, broiler breeding, broilers | Private; about 17–18% Quantum shareholder | — | Larger broiler producer (about 75 M birds vs Quantum's 45 M+ per WATTAgNet ranking) |
Sovereign Foods / Crown Chickens (Capitalworks) | Broilers, feed | Private; about 15.5% Quantum shareholder (via Capitalworks) | — | Eastern Cape-based integrator |
AFGRI Animal Feeds | Feed | Private | — | National feed competitor |
Daybreak Farms | Broilers, feed | Private | — | Northern-region broiler competitor |
Other SA egg producers (for example Eggbert Eggs and regional producers) | Eggs, layer livestock | Mostly private | — | A fragmented egg market. Quantum is described as one of the largest egg suppliers |
Other SA layer-genetics distributors | Layer livestock | Private | — | Compete with Bergvlei / Lohmann |
Zambeef Products (LuSE/AIM) | Zambia: feed, poultry, eggs | Listed | n/d in sources reviewed | Largest integrated Zambian protein group |
Other Zambian and Ugandan hatcheries and feed millers | Other African countries | Private | — | Competing day-old chick and feed suppliers |
Peer Comparison FY2025
| Metric | Quantum Foods (FY Sep 2025) | Astral Foods (FY Sep 2025) | Rainbow Chicken (FY Jun 2026) | RCL Foods (FY Jun 2025) |
|---|---|---|---|---|
Revenue (ZAR Bn) | 7.15 | 22.6 | 17.1 | 26.5 |
Revenue growth (%) | 12.9 | 10.4 | 7.7 | 1.8 |
Operating / PBIT margin (%) | 5.2 | 5.5 | n/d (EBITDA margin about 12.5%) | n/d (EBITDA margin about 9.7%) |
Headline EPS (cents) | 134.4 | 2,193 | 150.87 | — |
Dividend per share (cents) | 34 | 1,100 | 135 (incl. 75c special) | 60 |



